Rodríguez-Flores, Marcela
Goicochea-Turcott, Eduardo W.
Mancillas-Adame, Leonardo
Garibay-Nieto, Nayely
López-Cervantes, Malaquías
Rojas-Russell, Mario E.
Castro-Porras, Lilia V.
Gutiérrez-León, Eduardo http://orcid.org/0000-0001-5833-0932
Campos-Calderón, Luis F.
Pedraza-Escudero, Karen
Aguilar-Cuarto, Karina
Villanueva-Ortega, Eréndira
Hernández-Ruíz, Joselin http://orcid.org/0000-0002-0571-2563
Guerrero-Avendaño, Guadalupe
Monzalvo-Reyes, Sheyla M.
García-Rascón, Rafael
Gil-Velázquez, Israel N.
Cortés-Hernández, Dora E.
Granados-Shiroma, Marcela
Alvarez-Rodríguez, Brenda G.
Cabello-Garza, Martha L. http://orcid.org/0000-0001-6580-9650
González-Contreras, Zaira L.
Picazo-Palencia, Esteban http://orcid.org/0000-0002-2456-7955
Cerda-Arteaga, Juana M.
Pérez-Gómez, Héctor R.
Calva-Rodríguez, Roberto
Sánchez-Rodríguez, Gerardo
Carpio-Vázquez, Leslie D.
Dávalos-Herrera, María A.
Villatoro-de-Pleitez, Karla M.
Suárez-López, Melissa D.
Nevárez-Carrillo, María G.
Pérez-Alcántara, Karina
Mehta, Roopa http://orcid.org/0000-0002-2509-8054
Diez, Edurne Sandoval
Gregg, Edward W.
Article History
Received: 26 April 2021
Revised: 12 October 2021
Accepted: 26 October 2021
First Online: 1 January 2022
Competing interests
: MRF has received support from Medtronic, CONACYT, Novo Nordisk and Merck; EWGT has received support from Wyeth Science Centre; RM has received fees as speaker or advisor from Abbott, Amgen, Astra Zeneca, Boehringer Ingelheim, Janssen, Novo Nordisk, Sanofi and Silanes; LGMA has received fees from Novo Nordisk, Lilly, Merck and Sanofi. The rest of authors declare no competing interests.